UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 1, 2016
ABEONA THERAPEUTICS INC.
(Exact name of registrant as specified in its charter)
Delaware | 0-9314 | 83-0221517 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
3333 Lee Parkway, Suite 600
Dallas, TX 75219
(Address of principal executive offices) (Zip Code)
(214)-665-9495
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
On November 1, 2016, Abeona Therapeutics Inc. issued a press release entitled “Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock”. The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) | Exhibits. |
Exhibit No. | Description | |
99.1 | Press release dated November 1, 2016, entitled “Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Abeona Therapeutics Inc. | ||
(Registrant) | ||
By: | /s/ Stephen B. Thompson | |
Stephen B. Thompson Vice President Finance Chief Accounting Officer |
Dated: November 1, 2016
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Press release dated November 1, 2016, entitled “Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock” |